LOGIN  |  REGISTER
Chimerix

Pennant Reports First Quarter 2024 Results

May 06, 2024 | Last Trade: US$31.14 0.64 2.10

EAGLE, Idaho, May 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the first quarter of 2024, reporting GAAP diluted earnings per share of $0.16 for the first quarter of 2024. Pennant also reported adjusted diluted earnings per share of $0.20 for the quarter (1).

First Quarter Highlights

  • Total revenue for the quarter was $156.9 million, an increase of $30.5 million or 24.1% over the prior year quarter;
  • Net income for the first quarter was $4.9 million, an increase of $3.1 million or 165.2% over the prior year quarter;
  • Adjusted net income for the first quarter was $6.0 million, an increase of $2.1 million or 55.0% over the prior year quarter;
  • Segment Adjusted EBITDAR from Operations for the first quarter was $21.4 million, an increase of $4.3 million or 24.9% over the prior year quarter;
  • Adjusted EBITDA for the first quarter was $11.2 million, an increase of $3.3 million or 41.8% over the prior year quarter;
  • Home Health and Hospice Services segment revenue for the first quarter was $116.5 million, an increase of $25.4 million or 27.9% over the prior year quarter;
  • Home Health and Hospice Services segment adjusted EBITDAR from operations for the first quarter was $19.6 million, an increase of $5.1 million or 35.7% over the prior year quarter; and segment adjusted EBITDA from operations the first quarter was $17.9 million, an increase of $4.7 million or 35.7% over the prior year quarter;
  • Total home health admissions for the first quarter were 14,649, an increase of 3,739 or 34.3% over the prior year quarter; total Medicare home health admissions for the first quarter were 6,346, an increase of 1,398 or 28.3% over the prior year quarter;
  • Hospice average daily census for the first quarter was 2,962, an increase of 523 or 21.4% compared to the prior year quarter;
  • Senior Living Services segment revenue for the first quarter was $40.4 million, an increase of $5.0 million or 14.2% over the prior year quarter; average occupancy for the first quarter was 78.5%, an increase of 40 basis points over the prior year quarter, and average monthly revenue per occupied room for the first quarter was $4,667 an increase of $367 or 8.5% over the prior year quarter;
  • Same store(2) Senior Living Services segment revenue for the first quarter was $38.9 million, an increase of $3.6 million or 10.2% over the prior year quarter; same store senior living average occupancy for the first quarter was 79.7%, an increase of 60 basis points over the prior year quarter, and average monthly revenue per occupied room for the first quarter was $4,643 an increase of $349 or 8.1% over the prior year quarter;
  • Senior Living segment adjusted EBITDAR from operations for the first quarter was $12.0 million, an increase of $1.8 million or 17.3% over the prior year quarter; and segment adjusted EBITDA from Operations for the first quarter was $3.5 million, an increase of $1.3 million or 55.6% over the prior year quarter.

(1)  See "Reconciliation of GAAP to Non-GAAP Financial Information.”
(2) Same store senior living results is defined as all senior living communities excluding affiliate memory care units in transition, and new senior living operations acquired in 2023 or 2024.

Operating Results

“We are pleased to report a strong first quarter and great start to the year,” said Brent Guerisoli, Pennant’s Chief Executive Officer. “We continue to experience accelerated growth and are encouraged to see our focus on margin result in solid bottom-line improvement. Our home health and hospice segment achieved record setting performance in both revenue and earnings and our senior living segment reached an all-time high in revenue and steady improvement in earnings. Our on-going investment in leadership is building a foundation of strength across the organization and the Company’s first quarter performance positions us to deliver on 2024 expectations.”

A discussion of the Company's use of Non-GAAP financial measures is set forth below. A reconciliation of net income to EBITDA, adjusted EBITDAR and adjusted EBITDA, as well as a reconciliation of GAAP earnings per share, net income to adjusted net earnings per share and adjusted net income, appear in the financial data portion of this release. More complete information is contained in the Company’s Form 10-Q for the three months ended March 31, 2024, which has been filed with the SEC today and can be viewed on the Company’s website at www.pennantgroup.com

Conference Call

A live webcast will be held tomorrow, May 7, 2024 at 10:00 a.m. Mountain time (12:00 p.m. Eastern time) to discuss Pennant’s first quarter 2024 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Pennant’s website at https://investor.pennantgroup.com. The webcast will be recorded and will be available for replay via the website.

About Pennant

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 112 home health and hospice agencies and 53 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and/or 10-K, for a more complete discussion of the risks and other factors that could affect Pennant’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Pennant does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Contact Information

Investor Relations
The Pennant Group, Inc.
(208) 506-6100
This email address is being protected from spambots. You need JavaScript enabled to view it. 

 
THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(unaudited, in thousands, except for per-share amounts)
 
 Three Months Ended March 31,
  2024   2023 
    
Revenue$156,915  $126,464 
    
Expense:   
Cost of services 125,995   102,602 
Rent—cost of services 10,384   9,597 
General and administrative expense 11,436   8,705 
Depreciation and amortization 1,331   1,280 
Gain on disposition of property and equipment, net (755)   
Total expenses 148,391   122,184 
Income from operations 8,524   4,280 
Other income (expense), net:   
Other income 85   30 
Interest expense, net (1,792)  (1,406)
Other expense, net (1,707)  (1,376)
Income before provision for income taxes 6,817   2,904 
Provision for income taxes 1,759   907 
Net income 5,058   1,997 
Less: Net income attributable to noncontrolling interest 152   147 
Net income attributable to The Pennant Group, Inc.$4,906  $1,850 
Earnings per share:   
Basic$0.16  $0.06 
Diluted$0.16  $0.06 
Weighted average common shares outstanding:   
Basic 30,046   29,751 
Diluted 30,403   30,147 
        

 

THE PENNANT GROUP, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except par value)
 
 March 31, 2024 December 31, 2023
Assets   
Current assets:   
Cash$2,722  $6,059 
Accounts receivable—less allowance for doubtful accounts of $197 and $259, respectively 71,354   61,116 
Prepaid expenses and other current assets 12,987   12,902 
Total current assets 87,063   80,077 
Property and equipment, net 40,592   28,598 
Right-of-use assets 258,775   262,923 
Restricted and other assets 9,651   9,337 
Goodwill 107,220   91,014 
Other indefinite-lived intangibles 74,942   67,742 
Total assets$578,243  $539,691 
Liabilities and equity   
Current liabilities:   
Accounts payable$13,060  $10,841 
Accrued wages and related liabilities 25,254   28,256 
Operating lease liabilities—current 17,378   17,122 
Other accrued liabilities 19,543   15,330 
Total current liabilities 75,235   71,549 
Long-term operating lease liabilities—less current portion 244,180   248,596 
Deferred tax liabilities, net 2,140   1,855 
Other long-term liabilities 9,162   8,262 
Long-term debt, net 83,294   63,914 
Total liabilities 414,011   394,176 
Commitments and contingencies   
Equity:   
Common stock, $0.001 par value; 100,000 shares authorized; 30,371 and 30,036 shares issued and outstanding, respectively, at March 31, 2024; and 30,297 and 29,948 shares issued and outstanding, respectively, at December 31, 2023 30   29 
Additional paid-in capital 107,644   105,712 
Retained earnings 39,569   34,663 
Treasury stock, at cost, 3 shares at March 31, 2024 and December 31, 2023 (65)  (65)
Total The Pennant Group, Inc. stockholders’ equity 147,178   140,339 
Noncontrolling interest 17,054   5,176 
Total equity 164,232   145,515 
Total liabilities and equity$578,243  $539,691 
 

 

THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 
The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:
 
 Three Months Ended March 31,
  2024   2023 
Net cash provided by operating activities$545  $8,996 
Net cash used in investing activities (23,636)  (2,326)
Net cash provided by (used in) financing activities 19,754   (5,797)
Net (decrease) increase in cash (3,337)  873 
Cash beginning of period 6,059   2,079 
Cash end of period$2,722  $2,952 
 

 

THE PENNANT GROUP, INC.
REVENUE BY SEGMENT
(unaudited, dollars in thousands)
 
The following table sets forth our total revenue by segment and as a percentage of total revenue for the periods indicated:
 
 Three Months Ended March 31,
  2024   2023 
 Revenue
Dollars
 Revenue
Percentage
 Revenue
Dollars
 Revenue
Percentage
        
Home health and hospice services       
Home health$57,212 36.5% $41,780 33.0%
Hospice 54,607 34.8   43,289 34.2 
Home care and other(a) 4,671 3.0   6,010 4.8 
Total home health and hospice services 116,490 74.3   91,079 72.0 
Senior living services 40,425 25.7   35,385 28.0 
Total revenue$156,915 100.0% $126,464 100.0%
 
(a)  Home care and other revenue is included with home health revenue in other disclosures in this press release.
 

 

THE PENNANT GROUP, INC.
SELECT PERFORMANCE INDICATORS
(unaudited, total revenue dollars in thousands)
 
The following table summarizes our overall home health and hospice performance indicators for the each of the dates or periods indicated:
 
 Three Months Ended
March 31,
    
  2024  2023 Change % Change
Total agency results:        
Home health and hospice revenue$116,490 $91,079  25,411 27.9%
        
Home health services:       
Total home health admissions 14,649  10,910  3,739 34.3%
Total Medicare home health admissions 6,346  4,948  1,398 28.3%
Average Medicare revenue per 60-day completed episode(a)$3,535 $3,419 $116 3.4%
Hospice services:       
Total hospice admissions 3,080  2,451  629 25.7%
Average daily census 2,962  2,439  523 21.4%
Hospice Medicare revenue per day$187 $183 $4 2.2%

 

 Three Months Ended
March 31,
    
  2024  2023 Change % Change
Same agency(b) results:        
Home health and hospice revenue$103,677 $91,079 $12,598 13.8%
        
Home health services:       
Total home health admissions 12,175  10,834  1,341 12.4%
Total Medicare home health admissions 5,359  4,915  444 9.0%
Average Medicare revenue per 60-day completed episode(a)$3,538 $3,419 $119 3.5%
Hospice services:       
Total hospice admissions 2,692  2,451  241 9.8%
Average daily census 2,699  2,439  260 10.7%
Hospice Medicare revenue per day$187 $183 $4 2.2%
 
(a)  The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
(b)  Same agency results represent all agencies purchased or licensed prior to January 1, 2023.
 
 

The following table summarizes our senior living performance indicators for the periods indicated:

 Three Months Ended
March 31,
  2024   2023 
Total senior living results:   
Senior living revenue$40,425  $35,385 
    
Occupancy 78.5%  78.1%
Average monthly revenue per occupied unit$4,667  $4,300 

 

 Three Months Ended
March 31,
  2024   2023 
Same store senior living(a) results:    
Senior living revenue$38,904  $35,314 
    
Occupancy 79.7%  79.1%
Average monthly revenue per occupied unit$4,643  $4,294 
 
(a)  Same store senior living results is defined as all senior living communities excluding affiliate memory care units in transition, and new senior living operations acquired in 2023 or 2024.
 

 

THE PENNANT GROUP, INC.
REVENUE BY PAYOR SOURCE
(unaudited, dollars in thousands)
 
The following table presents our total revenue by payor source as a percentage of total revenue for the periods indicated:
 
 Three Months Ended March 31,
  2024   2023 
 Revenue
Dollars
 Revenue
Percentage
 Revenue
Dollars
 Revenue
Percentage
        
Revenue:       
Medicare$76,981 49.1% $60,756 48.0%
Medicaid 25,066 16.0   17,631 14.0 
Subtotal 102,047 65.1   78,387 62.0 
Managed Care 20,122 12.8   17,126 13.5 
Private and Other(a) 34,746 22.1   30,951 24.5 
Total revenue$156,915 100.0% $126,464 100.0%
 
(a)  Private and other payors in our home health and hospice services segment includes revenue from all payors generated in home care operations.
 

 

THE PENNANT GROUP, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(unaudited, in thousands, except per share data)
 
The following table reconciles net income to Non-GAAP net income for the periods presented:
 
 Three Months Ended
March 31,
  2024   2023 
    
Net income attributable to The Pennant Group, Inc.$4,906  $1,850 
    
Non-GAAP adjustments   
Costs at start-up operations(a) 80   530 
Share-based compensation expense(b) 1,526   1,419 
Acquisition related costs and credit allowances(c) 137   32 
Costs associated with transitioning operations(d) (573)  99 
Unusual, non-recurring or redundant charges(e) 275   398 
Provision for income taxes on Non-GAAP adjustments(f) (389)  (482)
Non-GAAP net income$5,962  $3,846 
    
Dilutive Earnings Per Share As Reported   
Net Income$0.16  $0.06 
Average number of shares outstanding 30,403   30,147 
    
Adjusted Diluted Earnings Per Share    
Net Income$0.20  $0.13 
Average number of shares outstanding 30,403   30,147 
 

 

(a)Represents results related to start-up operations.
  Three Months Ended
March 31,
   2024   2023 
 Revenue$(2,410) $(2,607)
 Cost of services 2,328   2,810 
 Rent 156   322 
 Depreciation & amortization 6   5 
 Total Non-GAAP adjustment$80  $530 
     
  
(b)Represents share-based compensation expense incurred for the periods presented.
  Three Months Ended
March 31,
   2024   2023 
 Cost of services$762  $688 
 General and administrative 764   731 
 Total Non-GAAP adjustment$1,526  $1,419 
     
(c)Represents costs incurred to acquire an operation that are not capitalizable.

 

(d)During the three months ended March 31, 2023, an affiliate of the Company placed its memory care units into transition and is actively seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign.
  Three Months Ended
March 31,
   2024   2023 
 Cost of services (628)  47 
 Rent 52   52 
 Depreciation 3    
 Total Non-GAAP adjustment$(573) $99 
     
  
(e)Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
     
(f)Represents an adjustment to the provision for income tax to the year-to-date effective tax rate of 26.0% and 25.8% for the three months ended March 31, 2024 and 2023, respectively. This rate excludes the tax benefit of share-based payment awards.
  
  

The table below reconciles Consolidated net income to the Consolidated Non-GAAP financial measures, Consolidated Adjusted EBITDA, and to the Non-GAAP valuation measure, Consolidated Adjusted EBITDAR, for the periods presented:

 Three Months Ended
March 31,
  2024   2023 
    
Consolidated net income$5,058  $1,997 
Less: Net income attributable to noncontrolling interest 152   147 
Add: Provision for income taxes 1,759   907 
Net interest expense 1,792   1,406 
Depreciation and amortization 1,331   1,280 
Consolidated EBITDA 9,788   5,443 
Adjustments to Consolidated EBITDA   
Add: Costs at start-up operations(a) (82)  203 
Share-based compensation expense(b) 1,526   1,419 
Acquisition related costs and credit allowances(c) 137   32 
Costs associated with transitioning operations(d) (628)  47 
Unusual, non-recurring or redundant charges(e) 275   398 
Rent related to items (a) and (d) above 208   374 
Consolidated Adjusted EBITDA 11,224   7,916 
Rent—cost of services 10,384   9,597 
Rent related to items (a) and (d) above (208)  (374)
Adjusted rent—cost of services 10,176   9,223 
Consolidated Adjusted EBITDAR(f)$21,400   
 
(a)  Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.
(b)  Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(c)  Non-capitalizable costs associated with acquisitions, credit allowances, and write offs for amounts in dispute with the prior owners of certain acquired operations.
(d)  During the three months ended March 31, 2023, an affiliate of the Company placed its memory care units into transition and is actively seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign.
(e)  Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
(f)  This measure is a valuation measure and is displayed thusly, it is not a performance measure as it excludes rent expense, which is a normal and recurring operating expense and, as such, does not reflect our cash requirements for leasing commitments. Our presentation of Consolidated Adjusted EBITDAR should not be construed as a financial performance measure.
 
 

The following table present certain financial information regarding our reportable segments. General and administrative expenses are not allocated to the reportable segments and are included in “All Other”:

 Home Health and Hospice Services Senior Living Services All Other Total
Segment GAAP Financial Measures:       
Three Months Ended March 31, 2024       
Revenue$        116,490         $        40,425         $        —          $        156,915        
Segment Adjusted EBITDAR from Operations$        19,550         $        12,011         $        (10,161) $        21,400        
Three Months Ended March 31, 2023       
Revenue$        91,079         $        35,385         $        —          $        126,464        
Segment Adjusted EBITDAR from Operations$        14,412         $        10,241         $        (7,514) $        17,139        
             

The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to Condensed Consolidated Income from Operations:

 Three Months Ended March 31,
  2024   2023
    
Segment Adjusted EBITDAR from Operations(a)$        21,400          $        17,139        
Less: Depreciation and amortization         1,331                   1,280        
Rent—cost of services         10,384                   9,597        
Other income         85                   30        
Adjustments to Segment EBITDAR from Operations:   
Less: Costs at start-up operations(b)         (82)          203        
Share-based compensation expense(c)         1,526                   1,419        
Acquisition related costs and credit allowances(d)         137                   32        
Costs associated with transitioning operations(e)         (628)          47        
Unusual, non-recurring or redundant charges(f)         275                   398        
Add: Net income attributable to noncontrolling interest         152                   147        
Consolidated Income from Operations$        8,524          $        4,280        
 
(a)  Segment Adjusted EBITDAR from Operations is net income (loss) attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation, (3) acquisition related costs and credit allowances, (4) the costs associated with transitioning operations, (5) unusual, non-recurring or redundant charges, and (6) net income attributable to noncontrolling interest. General and administrative expenses are not allocated to the reportable segments, and are included as “All Other”, accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited.
(b)  Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.  
(c)  Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.  
(d)  Non-capitalizable costs associated with acquisitions, credit allowances, and write offs for amounts in dispute with the prior owners of certain acquired operations.  
(e)  During the three months ended March 31, 2023, an affiliate of the Company placed its memory care units into transition and is actively seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign.  
(f) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.  
 
 

 

The tables below reconcile Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for each reportable segment for the periods presented:

 Three Months Ended March 31,
 Home Health and Hospice Senior Living
  2024   2023   2024   2023 
        
Segment Adjusted EBITDAR from Operations$19,550  $14,412  $12,011  $10,241 
Less: Rent—cost of services 1,729   1,323   8,655   8,274 
Rent related to start-up and transitioning operations (65)  (93)  (143)  (281)
Segment Adjusted EBITDA from Operations$17,886  $13,182  $3,499  $2,248 
 

Discussion of Non-GAAP Financial Measures

EBITDA consists of net income before (a) interest expense, net, (b) (benefits) provisions for income taxes, and (c) depreciation and amortization. Adjusted EBITDA consists of net income attributable to the Company before (a) interest expense, net (b) (benefits) provisions for income taxes, (c) depreciation and amortization, (d) costs incurred for start-up operations, including rent and excluding depreciation, interest and income taxes, (e) share-based compensation expense, (f) non-capitalizable acquisition related costs and credit allowances, (g) net costs associated with transitioning operations, (h) unusual, non-recurring or redundant charges and (i) net income attributable to noncontrolling interest. Consolidated Adjusted EBITDAR is a valuation measure applicable to current periods only and consists of net income attributable to the Company before (a) interest expense, net, (b) (benefits) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) costs incurred for start-up operations, excluding rent, depreciation, interest and income taxes, (f) share-based compensation expense, (g) acquisition related costs and credit allowances, (h) redundant or non-recurring transition services costs, (i) costs associated with transitioning operations, (j) unusual, non-recurring or redundant charges and (j) net income attributable to noncontrolling interest. The company believes that the presentation of EBITDA, adjusted EBITDA, consolidated adjusted EBITDAR, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. The company believes disclosure of adjusted net income, adjusted net income per share, EBITDA, adjusted EBITDA and consolidated adjusted EBITDAR has economic substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measure provides useful information to investors, the specific manner in which management uses this measure, and some of the limitations associated with the use of this measure, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Pennant’s website at http://www.pennantgroup.com. 

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB